Financial statements Skinlab
Balance sheet of Skinlab
Company age:
Age:
3 y. 11 m. 7 d.
Balance sheet data of SKINLAB
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 10 798 607,16 | 10 619 634,10 |
| A. Fixed assets | 10 681 666,67 | 10 503 833,31 |
| B. Current assets | 116 940,49 | 115 800,79 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 10 798 607,16 | 10 619 634,10 |
| A. Equity | 1 117 228,83 | 10 543 763,55 |
| B. Liabilities and provisions for liabilities | 9 681 378,33 | 75 870,55 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 64 940,04 | 75 870,55 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.